Skip to main content
Premium Trial:

Request an Annual Quote

Leena Peltonen-Palotie Dies

Leena Peltonen-Palotie, the head human genetics at the Wellcome Trust Sanger Institute, died last week, the institute says. She was 57. Peltonen-Palotie studied population genetics and her group found mutations associated with schizophrenia, obesity, heart diseases among other disease. During her career, she also established a genetic research center at the University of California, Los Angeles, and was a member of the Scientific Council of the European Research Council. She also worked with the Academy of Finland, her country. "Academician Leena Peltonen-Palotie has been a role model, both to scientists around the world and to individuals who hope to embark on careers in research. She has left a void in the Finnish scientific community that will be impossible to fill," says Markku Mattila, president of the Academy of Finland, in a statement.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.